Texas: Leading the Global Effort to End Cancer
Some of the world’s most impactful cancer research is happening in Texas. The University of Texas MD Anderson Cancer Center in Houston is ranked No. 1 in the nation for cancer care, and The University of Texas at Austin is one of the top public research universities in the world.
The University of Texas System recently announced that MD Anderson will build a new, comprehensive cancer center and UT Austin will build a specialty hospital at what will become the UT Austin Medical Center.
Two strategic collaborations between MD Anderson and UT Austin, launched in 2019, provide opportunities for joint cancer research projects with unprecedented scope – from highly specialized, patient-centric clinical studies to broader projects aimed at reducing cancer diagnoses across society.
MD Anderson – UT Austin Strategic Collaboration
MD Anderson and UT Austin have a broad strategic initiative aimed at promoting cooperative research between the two institutions across a variety of cancer-related fields. The collaborative research program aims to leverage the unique strengths of both institutions to advance cancer research by identifying breakthroughs in prevention, early detection and treatment.
Collaboration in Oncological Data and Computational Science
The Oden Institute for Computational Engineering and Sciences, The Texas Advanced Computing Center (TACC) and MD Anderson are collaborating in oncological data and computational science research.
This collaboration combines:
- Medical expertise and rich medical data (MD Anderson)
- Mathematical modeling and computational medicine expertise (Oden Institute)
- Leading high-performance computing capabilities (TACC)
The Collaboration in Oncological Data and Computational Science has resulted in discoveries of several new clinical approaches for cancer treatment as well as novel insights for improving outcomes for patients with unmet needs. In 2023, this collaboration formalized its partnership by establishing the Joint Center for Computational Oncology, which hosts joint postdoctoral researchers and a number of collaborative research efforts.